Breaking News
November 15, 2018 - Researchers develop tool that speeds up analysis and publication of biomedical data
November 15, 2018 - Scientists identify mechanism used by lung cancer cells to obtain glucose
November 15, 2018 - Abnormalities in development of the brain could be involved in onset of autism, finds new study
November 15, 2018 - Soy protein equally effective as animal protein in building muscle strength
November 15, 2018 - American Academy of Pediatrics, Nov. 2-6
November 15, 2018 - Dopamine drives early addiction to heroin
November 15, 2018 - Variance in gut microbiome in Himalayan populations linked to dietary lifestyle | News Center
November 15, 2018 - Reducing Cardiovascular Disease: The Amish Way
November 15, 2018 - King’s researchers launch charter to guide organizations to engage abuse survivors in research
November 15, 2018 - Enable Injections enters into development agreements with UCB and Apellis Pharmaceuticals
November 15, 2018 - TGen North collaborates with NARBHA Institute to advance human health
November 15, 2018 - Researchers discover molecular basis for therapeutic actions of an African folk medicine
November 15, 2018 - Human Cell Atlas study of early pregnancy shows how mother’s immune system is modified
November 15, 2018 - New guidelines for detecting and managing sarcopenia to be launched in the UK
November 15, 2018 - Researchers explore role of dietary composition on energy expenditure
November 15, 2018 - Elsevier launches Entellect™ Platform, unlocking value by creating AI-ready life sciences data
November 15, 2018 - Now that cannabis is legal in Canada, let’s use it to tackle the opioid crisis
November 15, 2018 - In the Spotlight: At the intersection of tech, health, and ethics
November 15, 2018 - Traditional Glaucoma Test Can Miss Severity of the Disease
November 15, 2018 - Researchers directly connect activities of genes with instinctive behavior in male cichlids
November 15, 2018 - Salk researchers report new methods to identify AD drug candidates with anti-aging properties
November 15, 2018 - St. Jude Hospital announces availability of largest collections of leukemia samples
November 15, 2018 - Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline
November 15, 2018 - Designing a novel cell-permeable peptide chimera to promote wound healing
November 15, 2018 - NEI investigators combine two imaging modalities to view the retina in unprecedented detail
November 15, 2018 - Determining how hearts develop to better understand congenital heart defects
November 15, 2018 - Maverick immune cells can act independently to identify and kill cancer cells, finds research
November 15, 2018 - Advanced AI and big data methods to tackle dementia
November 15, 2018 - Report reveals increase in pancreatic cancer death rates across Europe
November 15, 2018 - Luxia Scientific announces availability of its gut microbiome test in Luxembourg
November 15, 2018 - New diabetes drugs linked to increased risk of lower-limb amputation and ketoacidosis
November 15, 2018 - Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine
November 15, 2018 - Heart failure patients shouldn’t stop meds even if condition improves: study
November 15, 2018 - RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders
November 15, 2018 - Breakthrough research could lead to a new wave of cancer-fighting antibodies
November 15, 2018 - Mylan and Biocon launch new insulin glargine biosimilar in the UK
November 15, 2018 - For wildfire safety, only particular masks guard against toxic particulate matter
November 15, 2018 - New study of tribe shows influence of Western diet and lifestyle on blood pressure
November 15, 2018 - Scientists harness power of natural killer cells to treat children with neuroblastoma
November 15, 2018 - Investigating foodborne disease outbreak in Bosnia and Herzegovina based on simulation game
November 15, 2018 - Recommendations Issued for Management of Bradycardia
November 15, 2018 - Benefit unclear due to a lack of suitable studies
November 15, 2018 - TAMEST recognizes UT Southwestern’s Ralph DeBerardinis for changing our understanding of cancer
November 15, 2018 - Researchers discover key factors behind intestinal inflammation in CVID patients
November 15, 2018 - CityU develops first microarrayed 3D neuronal culture platform
November 15, 2018 - Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women
November 15, 2018 - New edition of Red Journal focuses on roles of imaging in radiation oncology
November 15, 2018 - Doctors Aren’t Promoting Breastfeeding’s Cancer-Protection Benefit
November 15, 2018 - Collection of demonstration projects highlights value of patient engagement in research
November 15, 2018 - Technique to ‘listen’ to a patient’s brain during tumour surgery
November 15, 2018 - Seven-year-old returns to life as a “normal, healthy child” following bone marrow transplant
November 15, 2018 - AMSBIO expands range of high quality FFPE cancer cell line controls
November 15, 2018 - Marijuana use by kidney donors has no effect on transplant outcomes
November 15, 2018 - Exploring NMR Spectroscopy Applications through Interesting Infographics
November 15, 2018 - Chapman University wins additional $2.9 million NIH grant to study Alzheimer’s disease
November 15, 2018 - Microgel powder reduces infection and promotes healing
November 15, 2018 - Suicidal patients with prescribed access to psychotropic drugs should be closely monitored
November 15, 2018 - Nitric oxide-releasing technology shows potential to reduce healing time of diabetic foot ulcers
November 15, 2018 - Mass shootings may trigger unnecessary blood donations
November 15, 2018 - From heart disease to cancer: New study tracks shift of county death rates
November 15, 2018 - Preventing falls with new sensor technology
November 15, 2018 - Promising technology could improve detection, diagnosis of fatal ovarian cancer
November 15, 2018 - AAP updates concussion recommendations for children and teens
November 15, 2018 - Two genomic tests help identify most effective treatment for breast cancer patients
November 15, 2018 - Researchers evaluate efficacy of salivary biomarkers for early detection of oral cancer
November 15, 2018 - NIH awards $3.5 million to continue development of robotic system for treating brain tumors
November 15, 2018 - Researchers succeed in building protein nanotubes from tiny scaffolds
November 15, 2018 - Rectal bleeding
November 15, 2018 - Nasal delivery of weight-loss hormone eases breathing problems in sleeping mice
November 15, 2018 - $9.6 million grant to fund research on vascular risk factors for brain aging, dementia | News Center
November 15, 2018 - Gum disease linked with diabetes
November 15, 2018 - Study identifies unique functional brain networks associated with ASD behaviors in infancy
November 15, 2018 - EU and industry-funded project aims to personalize diabetes treatment
November 15, 2018 - NIH researchers shed light on causes of HBV-associated acute liver failure
November 14, 2018 - FDA Alert: Implanted Pumps: Safety Communication
November 14, 2018 - Weight loss & acute Porphyria
November 14, 2018 - Researchers identify three sub-types of depression
November 14, 2018 - The puzzle of a mutated gene lurking behind many Parkinson’s cases | News Center
November 14, 2018 - The mystery viruses far worse than flu
November 14, 2018 - Research highlights physical changes in the brain of self-injuring teen girls
Breakthrough MRI technology using quantum physics

Breakthrough MRI technology using quantum physics

image_pdfDownload PDFimage_print

Magnetic Resonance Imaging (MRI) methods have been used widely in past decades as a safe, non-invasive and non-radioactive method of diagnosing CVDs. However, because of their limited sensitivity, even the most expensive MRI scanners (with the strongest magnets) cannot detect and visualize molecular and metabolic activity in the heart with sufficient sensitivity and specificity. To this end, emerging hyperpolarized MRI techniques play a pivotal role as they allow increasing the sensitivity of MRI by up to five orders of magnitude. Unfortunately, the hyperpolarization process takes a very long time (90-180 minutes per procedure), it is extremely costly and cumbersome (>$2million initial cost, room size equipment) and requires temperatures colder than -270 degrees Celsius. The MetaboliQs project therefore aims to enable a new method for MRI by leveraging new advances in quantum physics.

Precision diagnostics and personalized treatment using quantum physics

The method, termed “Hyperpolarized MRI”, will allow imaging and visualization of key metabolic substrates in the heart and other organs (e.g., kidney, liver) via hyperpolarization of nuclear spins of substrates that are natural to the body and non-toxic. In this way, a number of important metabolic reactions can be tracked non-invasively. This breakthrough technology will enable a previously unachievable, highly sensitive quantification of metabolic activity, paving the way for precision diagnostics and better personalized treatment of cardiovascular diseases. For example, it will become possible to distinguish patients who will most likely benefit from invasive or pharmacologic cardiac interventions from those who will need other medical treatment, and to accurately diagnose patients at the disease’s early stages.

The MetaboliQs project will leverage the transformative features of diamond nitrogen vacancies (NV), such as high quantum coherence and quantum control, to offer a breakthrough in Cardiac Hyperpolarized MRI: A low cost and high-throughput diamond polarizer that can be used with any MRI scanner and show results within minutes instead of hours required per procedure.

This unique utilization of quantum coherence is made possible by new technology to atomically engineer diamond material (quantum-grade diamond), including 12C isotopic purification, precise control of nitrogen defect concentration and nanofabrication of the diamond surface.

The MetaboliQs consortium, through its combination of leading research institutes and innovative companies, provides the end-to-end expertise required to reach the ambitious objectives of the project and develop breakthrough capabilities in hyperpolarized MRI for cardiovascular applications.
MetaboliQs brings together a world-class multidisciplinary consortium:

  1. Fraunhofer Institute for Applied Solid State Physics in Freiburg, Germany, a leading diamond quantum technology research institute and frontrunner in quantum-grade diamond growth and fabrication,
  2. NVision Imaging Technologies GmbH, Germany, Silicon-Valley backed Quantum Tech Company and inventor of diamond-based polarization,
  3. Element Six (UK) Limited, a world leader in research and production of synthetic diamond with a track record in the quantum space,
  4. The Hebrew University of Jerusalem (HUJI), Israel, leading diamond quantum technologies research institute,
  5. Bruker BioSpin GmbH- market leader in preclinical MRI and NMR spectroscopy

and two of the top technical universities in Europe with research groups in hyperpolarized and cardiovascular MRI:

  1. ETH Zurich in Switzerland
  2. and the Technical University of Munich, Germany.

The project MetaboliQs is part of the overall initiative “Quantum Flagship”, funded by the European Union. This initiative intends on placing Europe at the forefront of the second quantum revolution, which is now unfolding worldwide. It aims to bring disruptive quantum technologies to the scientific arena and to society in general by bringing forward new commercial opportunities addressing global challenges, providing strategic capabilities for security and seeding yet unimagined applications for the future. The Project MetaboliQs started in October 2018 and will continue until the end of 2021.

Source:

https://www.iaf.fraunhofer.de/en/media-library/press-releases/MetaboliQs.html ​

Tagged with:

About author

Related Articles